{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:49:10Z","timestamp":1745840950702,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00246-023-03388-3","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T09:02:44Z","timestamp":1706778164000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improving Palivizumab Administration to High-Risk Infants with Heart Disease via a Communication-Based Quality Improvement Initiative"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4296-4081","authenticated-orcid":false,"given":"David M.","family":"Leone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Cowenhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Ferdman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"3388_CR1","unstructured":"AAoP Committee on Infectious Diseases, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, Respiratory Syncytial Virus, in Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases. 2021, American Academy of Pediatrics. p. 0."},{"issue":"4","key":"3388_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1067\/s0022-3476(03)00454-2","volume":"143","author":"TF Feltes","year":"2003","unstructured":"Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM et al (2003) Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 143(4):532\u2013540. https:\/\/doi.org\/10.1067\/s0022-3476(03)00454-2","journal-title":"J Pediatr"},{"issue":"7","key":"3388_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJM198208123070702","volume":"307","author":"NE MacDonald","year":"1982","unstructured":"MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA (1982) Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 307(7):397\u2013400. https:\/\/doi.org\/10.1056\/NEJM198208123070702","journal-title":"N Engl J Med"},{"issue":"5","key":"3388_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3345\/kjp.2011.54.5.192","volume":"54","author":"JW Jung","year":"2011","unstructured":"Jung JW (2011) Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey. Korean J Pediatr 54(5):192\u2013196. https:\/\/doi.org\/10.3345\/kjp.2011.54.5.192","journal-title":"Korean J Pediatr"},{"key":"3388_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-1185-1_31","volume-title":"Respiratory Syncytial Virus Infection in Infants with Heart and Lung Diseases","author":"H Yamagishi","year":"2020","unstructured":"Yamagishi H (2020) Respiratory Syncytial Virus Infection in Infants with Heart and Lung Diseases. Springer, Singapore"},{"issue":"11","key":"3388_CR6","first-page":"013757","volume":"11","author":"L Garegnani","year":"2021","unstructured":"Garegnani L, Styrmisdottir L, Rodriguez PR, Liquitay CME, Esteban I, Franco JV (2021) Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev 11(11):013757","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3388_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","volume":"102","author":"TI-RS Group","year":"1998","unstructured":"TI-RS Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3):531\u2013537. https:\/\/doi.org\/10.1542\/peds.102.3.531","journal-title":"Pediatrics"},{"key":"3388_CR8","doi-asserted-by":"publisher","unstructured":"AP Publications Reaffirmed (2019) Pediatrics, 2019. 144(2) DOI: https:\/\/doi.org\/10.1542\/peds.2019-1767","DOI":"10.1542\/peds.2019-1767"},{"issue":"5","key":"3388_CR9","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","volume":"134","author":"SL Ralston","year":"2014","unstructured":"Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ et al (2014) Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134(5):e1474\u2013e1502. https:\/\/doi.org\/10.1542\/peds.2014-2742","journal-title":"Pediatrics"},{"issue":"2","key":"3388_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/peds.2014-1665","volume":"134","author":"MT Brady","year":"2014","unstructured":"Brady MT, Byington CL, Davies HD, Edwards KM, Jackson MA, Maldonado YA, Murray DL, Orenstein WA et al (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415\u2013420. https:\/\/doi.org\/10.1542\/peds.2014-1665","journal-title":"Pediatrics"},{"issue":"2","key":"3388_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/peds.2014-1665","volume":"134","author":"D American Academy of Pediatrics Committee on Infectious and C American Academy of Pediatrics Bronchiolitis Guidelines","year":"2014","unstructured":"D American Academy of Pediatrics Committee on Infectious and C American Academy of Pediatrics Bronchiolitis Guidelines (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415\u2013420. https:\/\/doi.org\/10.1542\/peds.2014-1665","journal-title":"Pediatrics"},{"key":"3388_CR12","unstructured":"AAoP (AAP) (2022) Updated guidance: use of palivizumab prophylaxis to prevent hospitalization from severe respiratory syncytial virus infection during the 2022\u20132023 RSV season"},{"key":"3388_CR13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052089","author":"R Agha","year":"2021","unstructured":"Agha R, Avner JR (2021) Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2021-052089","journal-title":"Pediatrics"},{"key":"3388_CR14","unstructured":"TNRaEVSS (NREVSS) (2023) Respiratory syncytial virus state trends: connecticut. Available from: https:\/\/www.cdc.gov\/surveillance\/nrevss\/rsv\/state.html#CT. Accessed 18 April 2023"},{"key":"3388_CR15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-047092","author":"BK Ackerson","year":"2021","unstructured":"Ackerson BK, Sy LS, Glenn SC, Qian L, Park CH, Riewerts RJ, Jacobsen SJ (2021) Pediatric vaccination during the COVID-19 pandemic. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2020-047092","journal-title":"Pediatrics"},{"issue":"19","key":"3388_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.15585\/mmwr.mm6919e2","volume":"69","author":"JM Santoli","year":"2020","unstructured":"Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, Gee J, Glover M et al (2020) Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration-United States, 2020. MMWR Morb Mortal Wkly Rep 69(19):591\u2013593. https:\/\/doi.org\/10.15585\/mmwr.mm6919e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"3388_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","volume":"386","author":"LL Hammitt","year":"2022","unstructured":"Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ et al (2022) Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med 386(9):837\u2013846. https:\/\/doi.org\/10.1056\/NEJMoa2110275","journal-title":"N Engl J Med"},{"issue":"388","key":"3388_CR18","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1126\/scitranslmed.aaj1928","volume":"9","author":"Q Zhu","year":"2017","unstructured":"Zhu Q, McLellan JS, Kallewaard NL, Ulbrandt ND, Palaszynski S, Zhang J, Moldt B, Khan A et al (2017) A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med 9(388):1928. https:\/\/doi.org\/10.1126\/scitranslmed.aaj1928","journal-title":"Sci Transl Med"},{"key":"3388_CR19","unstructured":"AR Book (2023) ACIP and AAP Recommendations for the Use of the Monoclonal Antibody Nirsevimab for the Prevention of RSV Disease"},{"key":"3388_CR20","unstructured":"CfDCaP (CDC) (2023) Limited Availability of Nirsevimab in the United States\u2014Interim CDC recommendations to protect infants from respiratory syncytial virus (RSV) during the 2023\u20132024 respiratory virus season"},{"issue":"5","key":"3388_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/nejmoa1913556","volume":"383","author":"MP Griffin","year":"2020","unstructured":"Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Sim\u00f5es EAF, Esser MT et al (2020) Single-dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med 383(5):415\u2013425. https:\/\/doi.org\/10.1056\/nejmoa1913556","journal-title":"N Engl J Med"},{"issue":"9","key":"3388_CR22","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/nejmc2112186","volume":"386","author":"J Domachowske","year":"2022","unstructured":"Domachowske J, Madhi SA, Sim\u00f5es EAF, Atanasova V, Caba\u00f1as F, Furuno K, Garcia-Garcia ML, Grantina I et al (2022) Safety of nirsevimab for RSV in infants with heart or lung disease or prematurity. N Engl J Med 386(9):892\u2013894. https:\/\/doi.org\/10.1056\/nejmc2112186","journal-title":"N Engl J Med"},{"issue":"5","key":"3388_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/nejmoa1908380","volume":"383","author":"SA Madhi","year":"2020","unstructured":"Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Sim\u00f5es EAF, Swamy GK, Agrawal S et al (2020) Respiratory syncytial virus vaccination during pregnancy and effects in infants. N Engl J Med 383(5):426\u2013439. https:\/\/doi.org\/10.1056\/nejmoa1908380","journal-title":"N Engl J Med"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03388-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-023-03388-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03388-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T08:41:58Z","timestamp":1738399318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-023-03388-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3388"],"URL":"https:\/\/doi.org\/10.1007\/s00246-023-03388-3","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"type":"print","value":"0172-0643"},{"type":"electronic","value":"1432-1971"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}